Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 30

    1.

    The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly.

    Bernabeu I, Alvarez-Escolá C, Quinteiro C, Lucas T, Puig-Domingo M, Luque-Ramírez M, de Miguel-Novoa P, Fernandez-Rodriguez E, Halperin I, Loidi L, Casanueva FF, Marazuela M.

    J Clin Endocrinol Metab. 2009 Oct 29. [Epub ahead of print]PMID: 19850678 [PubMed - as supplied by publisher]Related articles

    2.

    The Efficacy of Octreotide LAR as Firstline Therapy for Patients with Newly Diagnosed Acromegaly is Independent of Tumor Extension: Predictive Factors of Tumor and Biochemical Response.

    Luque-Ramírez M, Portoles GR, Varela C, Albero R, Halperin I, Moreiro J, Soto A, Casamitjana R.

    Horm Metab Res. 2009 Oct 1. [Epub ahead of print]PMID: 19798622 [PubMed - as supplied by publisher]Related articles

    3.

    [Metastasis in the thyroid gland.]

    Gómez-Ramírez J, Bravo JM, Luque-Ramírez M, Martín-Pérez E, Larrañaga E.

    Cir Esp. 2009 Aug 13. [Epub ahead of print] Spanish. No abstract available. PMID: 19683222 [PubMed - as supplied by publisher]Related articlesFree article

    4.

    Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women.

    Alvarez-Blasco F, Martínez-García MA, Luque-Ramírez M, Parraza N, San Millán JL, Escobar-Morreale HF.

    PLoS One. 2009;4(5):e5606. Epub 2009 May 19.PMID: 19440331 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism.

    Martínez-García MA, Luque-Ramírez M, San-Millán JL, Escobar-Morreale HF.

    Diabetes Care. 2009 Aug;32(8):1525-30. Epub 2009 Apr 28.PMID: 19401444 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy.

    Marazuela M, Lucas T, Alvarez-Escolá C, Puig-Domingo M, de la Torre NG, de Miguel-Novoa P, Duran-Hervada A, Manzanares R, Luque-Ramírez M, Halperin I, Casanueva FF, Bernabeu I.

    Eur J Endocrinol. 2009 Apr;160(4):535-42. Epub 2009 Jan 15.PMID: 19147599 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.

    Luque-Ramírez M, Mendieta-Azcona C, del Rey Sánchez JM, Matíes M, Escobar-Morreale HF.

    Eur J Endocrinol. 2009 Mar;160(3):469-80. Epub 2009 Jan 12.PMID: 19139031 [PubMed - indexed for MEDLINE]Related articles

    8.

    Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome.

    Escobar-Morreale HF, Luque-Ramírez M, San-Millán JL.

    Diabetes Care. 2009 Jan;32(1):e6. No abstract available. PMID: 19114623 [PubMed - in process]Related articlesFree article

    9.

    Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients.

    Luque-Ramírez M, Alvarez-Blasco F, Escobar-Morreale HF.

    Obesity (Silver Spring). 2009 Jan;17(1):3-9. Epub 2008 Nov 6.PMID: 18997670 [PubMed - indexed for MEDLINE]Related articles

    10.

    99MTc-sestamibi as sole technique in selection of primary hyperparathyroidism patients for unilateral neck exploration.

    Moure D, Larrañaga E, Domínguez-Gadea L, Luque-Ramírez M, Nattero L, Gómez-Pan A, Marazuela M.

    Surgery. 2008 Sep;144(3):454-9.PMID: 18707045 [PubMed - indexed for MEDLINE]Related articles

    11.

    Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome.

    Escobar-Morreale HF, Botella-Carretero JI, Martínez-García MA, Luque-Ramírez M, Alvarez-Blasco F, San Millán JL.

    Eur J Endocrinol. 2008 Sep;159(3):225-32. Epub 2008 Jun 25.PMID: 18579554 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome.

    Luque-Ramírez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale HF.

    Fertil Steril. 2009 Jun;91(6):2527-36. Epub 2008 Jun 18.PMID: 18565522 [PubMed - indexed for MEDLINE]Related articles

    13.

    Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.

    Luque-Ramírez M, Alvarez-Blasco F, Uriol Rivera MG, Escobar-Morreale HF.

    Hum Reprod. 2008 Jul;23(7):1594-601. Epub 2008 Mar 27.PMID: 18375410 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery.

    Botella-Carretero JI, Luque-Ramírez M, Alvarez-Blasco F, Peromingo R, San Millán JL, Escobar-Morreale HF.

    Obes Surg. 2008 Aug;18(8):1000-6. Epub 2008 Mar 19.PMID: 18350343 [PubMed - indexed for MEDLINE]Related articles

    15.

    The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event.

    Botella-Carretero JI, Alvarez-Blasco F, Martinez-García MA, Luque-Ramírez M, San Millán JL, Escobar-Morreale HF.

    Obes Surg. 2007 Sep;17(9):1199-208.PMID: 18074495 [PubMed - indexed for MEDLINE]Related articles

    16.

    Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.

    Luque-Ramírez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale HF.

    Hum Reprod. 2007 Dec;22(12):3197-203. Epub 2007 Oct 11.PMID: 17933750 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Obesity and the polycystic ovary syndrome.

    Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF.

    Minerva Endocrinol. 2007 Sep;32(3):129-40. Review.PMID: 17912153 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cost of management of invasive growth hormone-secreting macroadenoma.

    Luque-Ramírez M, Paramo C, Varela da Costa C, García-Mayor RV.

    J Endocrinol Invest. 2007 Jul-Aug;30(7):541-5.PMID: 17848835 [PubMed - indexed for MEDLINE]Related articles

    19.

    Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.

    Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Sanchón R, San Millán JL, Escobar-Morreale HF.

    Diabetes Care. 2007 Sep;30(9):2309-13. Epub 2007 May 29.PMID: 17536071 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.

    Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Martínez-Bermejo E, Lasunción MA, Escobar-Morreale HF.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2453-61. Epub 2007 Apr 10.PMID: 17426085 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome.

    Luque-Ramírez M, Alvarez-Blasco F, Mendieta-Azcona C, Botella-Carretero JI, Escobar-Morreale HF.

    J Clin Endocrinol Metab. 2007 Jun;92(6):2141-8. Epub 2007 Mar 27.PMID: 17389696 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    [Hungry bone syndrome related to hyperthyroidism]

    Moure Rodríguez MD, Luque-Ramírez M, López Gallardo G, López Iglesias M, Gómez-Pan A.

    An Med Interna. 2006 Jul;23(7):326-8. Spanish. PMID: 17067232 [PubMed - indexed for MEDLINE]Related articles

    23.

    Mutations in the hereditary hemochromatosis gene are not associated with the increased body iron stores observed in overweight and obese women with polycystic ovary syndrome.

    Botella-Carretero JI, Luque-Ramírez M, Alvarez-Blasco F, San Millán JL, Escobar-Morreale HF.

    Diabetes Care. 2006 Nov;29(11):2556. No abstract available. PMID: 17065702 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.

    San Millán JL, Alvarez-Blasco F, Luque-Ramírez M, Botella-Carretero JI, Escobar-Morreale HF.

    Hum Reprod. 2006 Dec;21(12):3157-61. Epub 2006 Jul 31.PMID: 16880229 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study.

    Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Alvarez-Blasco F, Sanchón R, Luque-Ramírez M, San Millán JL.

    Hum Reprod. 2006 Sep;21(9):2257-65. Epub 2006 May 4.PMID: 16675483 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Genomic variants in polycystic ovary syndrome.

    Luque-Ramírez M, San Millán JL, Escobar-Morreale HF.

    Clin Chim Acta. 2006 Apr;366(1-2):14-26. Epub 2005 Dec 7. Review.PMID: 16337616 [PubMed - indexed for MEDLINE]Related articles

    27.

    Body iron stores are increased in overweight and obese women with polycystic ovary syndrome.

    Escobar-Morreale HF, Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Sancho J, San Millán JL.

    Diabetes Care. 2005 Aug;28(8):2042-4. No abstract available. PMID: 16043756 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome.

    San Millán JL, Botella-Carretero JI, Alvarez-Blasco F, Luque-Ramírez M, Sancho J, Moghetti P, Escobar-Morreale HF.

    J Clin Endocrinol Metab. 2005 Jul;90(7):4157-62. Epub 2005 Apr 12.PMID: 15827106 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.

    Escobar-Morreale HF, Luque-Ramírez M, San Millán JL.

    Endocr Rev. 2005 Apr;26(2):251-82. Epub 2004 Nov 23. Review.PMID: 15561799 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    [Severe hyponatremia associated with the use of fluoxetine in the elderly]

    Luque Ramírez M, Bajo Martínez A, Bernal Morell E, Manzano Espinosa L.

    Rev Clin Esp. 2002 Apr;202(4):246. Spanish. No abstract available. PMID: 12003744 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...